Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jocelyne Mulangala

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Circulation Research|June 10, 2021
Bench-to-Bedside in Vascular Medicine: Optimizing the Translational Pipeline for Patients With Peripheral Artery DiseaseTom Alsaigh, Belinda A Di Bartolo, Jocelyne Mulangala, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 22, 2025
Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery DiseaseJordyn M Thomas, Panashe Bamhare, Jocelyne Mulangala, et al.
International Journal of Molecular Sciences|March 28, 2024
TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated AngiogenesisNathan K P Wong, Emma L Solly, Richard Le, et al.
Diabetes|March 31, 2026
Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound HealingEmma L Solly, Yingjun Luo, Khalia R Primer, et al.
International Journal of Molecular Sciences|March 25, 2022
Pro-Calcific Environment Impairs Ischaemia-Driven AngiogenesisJocelyne Mulangala, Emma J Akers, Emma L Solly, et al.
Geroscience|October 2, 2023
Vascular senescence and leak are features of the early breakdown of the blood-brain barrier in Alzheimer's disease modelsKa Ka Ting, Paul Coleman, Hani Jieun Kim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2018
VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemiaCarla M Cannizzo, Aaron A Adonopulos, Emma L Solly, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Circulation Research|June 10, 2021
Bench-to-Bedside in Vascular Medicine: Optimizing the Translational Pipeline for Patients With Peripheral Artery DiseaseTom Alsaigh, Belinda A Di Bartolo, Jocelyne Mulangala, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 22, 2025
Apolipoprotein C3 Promotes Angiogenesis in an Inflammatory Mouse Model of Peripheral Artery DiseaseJordyn M Thomas, Panashe Bamhare, Jocelyne Mulangala, et al.
International Journal of Molecular Sciences|March 28, 2024
TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated AngiogenesisNathan K P Wong, Emma L Solly, Richard Le, et al.
Diabetes|March 31, 2026
Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound HealingEmma L Solly, Yingjun Luo, Khalia R Primer, et al.
International Journal of Molecular Sciences|March 25, 2022
Pro-Calcific Environment Impairs Ischaemia-Driven AngiogenesisJocelyne Mulangala, Emma J Akers, Emma L Solly, et al.
Geroscience|October 2, 2023
Vascular senescence and leak are features of the early breakdown of the blood-brain barrier in Alzheimer's disease modelsKa Ka Ting, Paul Coleman, Hani Jieun Kim, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2018
VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemiaCarla M Cannizzo, Aaron A Adonopulos, Emma L Solly, et al.
Pageof 1